Grenada

Resilience System


You are here

Treatments

Ivermectin: Higher dose, longer duration still ineffective for COVID, new trial finds

A randomized, controlled trial (RCT) shows that even at a higher dose and longer treatment duration, the antimalarial drug ivermectin didn't shorten the time to a sustained recovery from COVID-19.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

COVID increases risk for cardiac complications—suggestions for protection

...

With COVID here to stay, what can the average person do to protect their heart?

Keeping heart-healthy pre-COVID looks largely the same during COVID, Dr. Michelle Albert, president of the American Heart Association, tells Fortune.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Asthma patients report worse asthma control after COVID-19

People with asthma in Hong Kong experienced worse control of their asthma after they had recovered from mild to moderate COVID-19, according to findings yesterday in Respiratory Research.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

The COVID Pandemic Is Not Over For Older Persons

...

For older Americans, the pandemic still poses significant dangers. About three-quarters of Covid deaths have occurred in people over 65, with the greatest losses concentrated among those over 75.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Two new studies indicate Paxlovid's usefulness in helping prevent hospitalization, death in COVID outpatients

Two new studies, one from the United States and one from Canada, suggest that the oral antiviral drug Paxlovid (nirmatrelvir-ritonavir) is effective in lowering the odds of hospitalization or death from the SARS-CoV-2 Omicron subvariant.

...

 

 

 

 

 

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Treatments
howdy folks
Page loaded in 1.000 seconds.